Compared side by side
Pinealon vs vesugen: how they differ
The short answer
Both are tripeptides from the Russian bioregulator program, aimed at different tissues: pinealon at nerve cells, which it protected in cell and rodent studies, and vesugen at the blood-vessel wall, where it supported the renewal of the lining cells in cell studies. Their human data are small Russian studies with no placebo group. Both are run in courses rather than continuously, commonly 10–20 days a few times a year.
Side by side
| Compared | Pinealon | Vesugen |
|---|---|---|
| Category | Longevity | Longevity |
| Also known as | EDR peptide, Tripeptide-4, Glu-Asp-Arg | KED peptide, Lys-Glu-Asp, Vezugen |
| What it is | A short synthetic peptide from the Russian bioregulator program, designed from brain-tissue extracts (not pineal tissue, despite the name). | A short peptide from the Russian bioregulator program behind Epitalon and Pinealon, which its developers describe as a bioregulator for the blood-vessel wall. |
| How it works | Short synthetic tripeptide (Glu-Asp-Arg) designed from brain-cortex peptide extracts; the name refers to its intended target. Neuroprotective in cell and rodent studies from the developer's group, with small uncontrolled Russian reports of cognitive gains. Claimed to support melatonin, though no study has tested it. | A tripeptide, Lys-Glu-Asp (KED), from the Russian bioregulator program of Vladimir Khavinson's St. Petersburg Institute of Bioregulation and Gerontology, the group behind Epitalon and Pinealon. Its developers found it in their peptide extract of cattle blood vessels and describe it as the bioregulator of the vessel wall: in their scheme each short peptide regulates one tissue, by binding DNA and changing which genes are read. In cultures of the cells that line blood vessels it raised the markers of cell renewal and SIRT1 and brought endothelin-1, which rises in atherosclerosis, back toward normal; in mice bred to develop Alzheimer's disease, daily injections restored the stable "mushroom" spines where neurons connect. Its human data are a handful of small Russian studies with no placebo group. |
| Commonly reported | Vivid dreams and deeper sleep, and clearer thinking during the cycle. Typically used in short 10–20 day cycles a few times a year, often alongside Epitalon. | User reports are few; those shared describe more stamina and stronger pumps in training over a few weeks. |
| Studied range | Commonly run: 1–5 mg. No controlled study has set a dose of Pinealon: this is the range people commonly run, not a reference. | No controlled study has set a dose of Vesugen: the amounts people run are their own protocol, not a reference. |
| How often | Daily for 10–20 day cycles, 2–3 cycles per year | Daily |
| Half-life | Short | Unknown (never measured) |
| Route | SubQ injection, Nasal | SubQ injection, Oral capsules |
| Typical run | 10–20 day cycles, 2–3 times a year, similar to Epitalon. Often stacked with Epitalon in the same cycle. | Run in courses rather than continuously, like the other bioregulators. Its developers' capsules are labelled for a one-month course, repeated after 3–6 months; injected courses commonly run 10–20 days, a few times a year. No study has tested a course length. |
| Evidence | Emerging: primarily preclinical / limited human data | Emerging: primarily preclinical / limited human data |
| Common side effects | Vivid dreams, drowsiness, injection site reaction | Injection-site sting or itch, mild stomach upset (capsules) |
- Category
- PinealonLongevity
- VesugenLongevity
- Also known as
- PinealonEDR peptide, Tripeptide-4, Glu-Asp-Arg
- VesugenKED peptide, Lys-Glu-Asp, Vezugen
- What it is
- PinealonA short synthetic peptide from the Russian bioregulator program, designed from brain-tissue extracts (not pineal tissue, despite the name).
- VesugenA short peptide from the Russian bioregulator program behind Epitalon and Pinealon, which its developers describe as a bioregulator for the blood-vessel wall.
- How it works
- PinealonShort synthetic tripeptide (Glu-Asp-Arg) designed from brain-cortex peptide extracts; the name refers to its intended target. Neuroprotective in cell and rodent studies from the developer's group, with small uncontrolled Russian reports of cognitive gains. Claimed to support melatonin, though no study has tested it.
- VesugenA tripeptide, Lys-Glu-Asp (KED), from the Russian bioregulator program of Vladimir Khavinson's St. Petersburg Institute of Bioregulation and Gerontology, the group behind Epitalon and Pinealon. Its developers found it in their peptide extract of cattle blood vessels and describe it as the bioregulator of the vessel wall: in their scheme each short peptide regulates one tissue, by binding DNA and changing which genes are read. In cultures of the cells that line blood vessels it raised the markers of cell renewal and SIRT1 and brought endothelin-1, which rises in atherosclerosis, back toward normal; in mice bred to develop Alzheimer's disease, daily injections restored the stable "mushroom" spines where neurons connect. Its human data are a handful of small Russian studies with no placebo group.
- Commonly reported
- PinealonVivid dreams and deeper sleep, and clearer thinking during the cycle. Typically used in short 10–20 day cycles a few times a year, often alongside Epitalon.
- VesugenUser reports are few; those shared describe more stamina and stronger pumps in training over a few weeks.
- Studied range
- PinealonCommonly run: 1–5 mg. No controlled study has set a dose of Pinealon: this is the range people commonly run, not a reference.
- VesugenNo controlled study has set a dose of Vesugen: the amounts people run are their own protocol, not a reference.
- How often
- PinealonDaily for 10–20 day cycles, 2–3 cycles per year
- VesugenDaily
- Half-life
- PinealonShort
- VesugenUnknown (never measured)
- Route
- PinealonSubQ injection, Nasal
- VesugenSubQ injection, Oral capsules
- Typical run
- Pinealon10–20 day cycles, 2–3 times a year, similar to Epitalon. Often stacked with Epitalon in the same cycle.
- VesugenRun in courses rather than continuously, like the other bioregulators. Its developers' capsules are labelled for a one-month course, repeated after 3–6 months; injected courses commonly run 10–20 days, a few times a year. No study has tested a course length.
- Evidence
- PinealonEmerging: primarily preclinical / limited human data
- VesugenEmerging: primarily preclinical / limited human data
- Common side effects
- PinealonVivid dreams, drowsiness, injection site reaction
- VesugenInjection-site sting or itch, mild stomach upset (capsules)
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
Pinealon
- Day 1–10 The short cycle is the whole protocol
- Day 10–20 Cognitive clarity + closing the cycle
- Day 20–90 Off-cycle consolidation
Vesugen
- Day 1–14 Changes come over weeks
- Day 14–30 Where the studies measured blood flow
- Day 30–120 Courses spaced months apart
Together or one or the other
Pinealon and vesugen are a common stack: vesugen lists pinealon among its common stacks.
Community · Vesugen
Paired with Pinealon, as in the Russian studies
Vesugen and Pinealon are the bioregulator pair Russian studies have given together, one for the vessels and one for the brain; Epitalon often joins them in community stacks. None of those studies had a placebo group.
Questions people ask
How long do pinealon and vesugen last?
The half-life of pinealon is short. The half-life of vesugen is unknown (never measured).
How often are pinealon and vesugen taken?
Pinealon: daily for 10–20 day cycles, 2–3 cycles per year. Routes: SubQ injection, nasal. Vesugen: daily. Routes: SubQ injection, oral capsules.
How are pinealon and vesugen dosed in research?
pinealon is commonly run at 1–5 mg. No controlled study has set a dose of Pinealon: this is the range people commonly run, not a reference. The library carries no reference dose for vesugen. No controlled study has set a dose of Vesugen: the amounts people run are their own protocol, not a reference.
What are the common side effects of pinealon and vesugen?
For pinealon, the library lists: vivid dreams, drowsiness, injection site reaction. For vesugen: injection-site sting or itch, mild stomach upset (capsules).
Are pinealon and vesugen taken together?
Pinealon and vesugen are a common stack: vesugen lists pinealon among its common stacks. Vesugen and Pinealon are the bioregulator pair Russian studies have given together, one for the vessels and one for the brain; Epitalon often joins them in community stacks. None of those studies had a placebo group.